APA

Timmerman J., Herbaux C., Ribrag V., Zelenetz A. D., Houot R., Neelapu S. S., Logan T., Lossos I. S., Urba W., Salles G., Ramchandren R., Jacobson C., Godwin J., Carpio C., Lathers D., Liu Y., Neely J., Suryawanshi S., Koguchi Y. & Levy R. (20200603). Urelumab alone or in combination with rituximab in patients with relapsed or refractory B-cell lymphoma. : American journal of hematology.

Chicago

Timmerman John, Herbaux Charles, Ribrag Vincent, Zelenetz Andrew D, Houot Roch, Neelapu Sattva S, Logan Theodore, Lossos Izidore S, Urba Walter, Salles Gilles, Ramchandren Radhakrishnan, Jacobson Caron, Godwin John, Carpio Cecilia, Lathers Deanne, Liu Yali, Neely Jaclyn, Suryawanshi Satyendra, Koguchi Yoshinobu and Levy Ronald. 20200603. Urelumab alone or in combination with rituximab in patients with relapsed or refractory B-cell lymphoma. : American journal of hematology.

Harvard

Timmerman J., Herbaux C., Ribrag V., Zelenetz A. D., Houot R., Neelapu S. S., Logan T., Lossos I. S., Urba W., Salles G., Ramchandren R., Jacobson C., Godwin J., Carpio C., Lathers D., Liu Y., Neely J., Suryawanshi S., Koguchi Y. and Levy R. (20200603). Urelumab alone or in combination with rituximab in patients with relapsed or refractory B-cell lymphoma. : American journal of hematology.

MLA

Timmerman John, Herbaux Charles, Ribrag Vincent, Zelenetz Andrew D, Houot Roch, Neelapu Sattva S, Logan Theodore, Lossos Izidore S, Urba Walter, Salles Gilles, Ramchandren Radhakrishnan, Jacobson Caron, Godwin John, Carpio Cecilia, Lathers Deanne, Liu Yali, Neely Jaclyn, Suryawanshi Satyendra, Koguchi Yoshinobu and Levy Ronald. Urelumab alone or in combination with rituximab in patients with relapsed or refractory B-cell lymphoma. : American journal of hematology. 20200603.